For the first in vivo study, NSG mice were inoculated with 5 × 106 PSMA+ PC3-PIP tumour cells and treated on day 5 by peritumoral transfer of 5 × 106 4G CAR- or UTD-T cells (Extended Data Fig. 5c). This evidence concerns the gene FOLH1 and neoplasm.